ArticleCurrent oncology (Toronto, Ont.)2009

Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.

A Kapoor et al.PubMed ↗Full text ↗

No numbers read from the abstract.